Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Shanghai Menon Animal Nutrition Technology
301156
5
Nanjing Railway New Technology
301016
US Stock MarketDetailed Quotes
PHGE BiomX
- 0.5800
- -0.0058-0.99%
Close Apr 4 16:00 ET
- 0.5517
- -0.0283-4.88%
Post 16:02 ET
14.48MMarket Cap-0.17P/E (TTM)
0.6188High0.5505Low159.79KVolume0.6000Open0.5858Pre Close93.40KTurnover0.90%Turnover RatioLossP/E (Static)24.97MShares4.990052wk High2.64P/B10.31MFloat Cap0.477052wk Low--Dividend TTM17.77MShs Float119.0000Historical High--Div YieldTTM11.66%Amplitude0.4770Historical Low0.5840Avg Price1Lot Size
About BiomX Company
BiomX, Inc. operates as a clinical-stage microbiome company, which engages in the development of both natural and engineered phage cocktails designed to target and destroy harmful bacteria in chronic diseases, such as cystic fibrosis and atopic dermatitis. Its product pipelines include BX004 and BX005, which are treatments for cystic fibrosis and atopic dermatitis respectively. The company was founded in March 2015 and is headquartered in Ness Ziona, Israel.
Company Profile
SymbolPHGE
Company NameBiomX
Listing DateDec 14, 2018
Founded2015
CEOMr. Jonathan Solomon
MarketAMEX
Employees71
Fiscal Year Ends12-31
Address22 Einstein Street,Floor 4
CityNess Ziona
ProvinceTel Aviv
CountryIsrael
Zip Code70000
Phone972-72-394-2377
Websitehttp://www.biomx.com
Company Executives
- Name
- Position
- Salary
- Jonathan Solomon
- Director and Chief Executive Officer
- 1.12M
- Marina Wolfson
- Senior Vice President, Finance and Operations, Principal Accounting Officer and Chief Financial Officer
- 428.26K
- Dr. Merav Bassan, PhD
- Chief Development Officer
- 590.93K
- Dr. Russell Greig
- Chairman of the Board
- 161.58K
- Jonathan S. Leff
- Director
- --
- Gregory Merril
- Director
- --
- Dr. Jesse Goodman, M.D.,M.P.H.
- Director
- --
- Susan Blum
- Independent Director
- --
- Edward Williams
- Independent Director
- 8.79K
- Dr. Alan C. Moses, F.A.C.P.,M.D.
- Independent Director
- 81.43K
Market Insights
Discussing
Chinese stock earnings surge: Will profit sustain the rally?
1. Which sectors are likely to be market highlights this season? 2. With the government's emphasis on technological innovation and sustaina
Moomoo News Global
Mar 4 23:26
China's Two Sessions: Key Takeaways on Stock Price Movements Before and After the Meetings
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
